Lexapro maker squares off with generics in latest IP battle

Article 2018-04-16 9:19 pm By Miklos Bolza | Sydney

Please login to bookmark

The maker of the anti-depressant Lexapro faced off Monday against Apotex, Aspen Pharma and Sandoz at a court hearing over the rights to make generic versions of the top-selling product, with a barrister for Lundbeck slamming the three companies’ defence that their drugs were different.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au